Mercaptopurine and Myelodysplastic syndrome - a phase IV clinical study of FDA data
Myelodysplastic syndrome is found among people who take Mercaptopurine, especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years.
The phase IV clinical study analyzes which people take Mercaptopurine and have Myelodysplastic syndrome. It is created by eHealthMe based on reports of 17,723 people who have side effects when taking Mercaptopurine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
17,723 people reported to have side effects when taking Mercaptopurine.
Among them, 149 people (0.84%) have Myelodysplastic syndrome.
What is Mercaptopurine?
Mercaptopurine has active ingredients of mercaptopurine. It is often used in crohn's disease. eHealthMe is studying from 17,983 Mercaptopurine users for its effectiveness, alternative drugs and more.
What is Myelodysplastic syndrome?
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged) is found to be associated with 1,283 drugs and 982 conditions by eHealthMe.
Number of Mercaptopurine and Myelodysplastic syndrome reports submitted per year:
Time on Mercaptopurine when people have Myelodysplastic syndrome *:
Gender of people who have Myelodysplastic syndrome when taking Mercaptopurine*:
Age of people who have Myelodysplastic syndrome when taking Mercaptopurine *:
Common drugs people take besides Mercaptopurine *:
Common side effects people have besides Myelodysplastic syndrome *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Mercaptopurine and have Myelodysplastic syndrome?Check whether Myelodysplastic syndrome is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .
How severe was Myelodysplastic syndrome and when was it recovered:
Expand to all the drugs that have ingredients of mercaptopurine:
Alternative drugs to, pros and cons of Mercaptopurine:
- Mercaptopurine (17,983 reports)
Common Mercaptopurine side effects:
Browse all side effects of Mercaptopurine:a b c d e f g h i j k l m n o p q r s t u v w x y z
Myelodysplastic syndrome treatments and more:
- Myelodysplastic syndrome (49,651 reports)
COVID vaccines that are related to Myelodysplastic syndrome:
- Myelodysplastic syndrome in Moderna COVID Vaccine
- Myelodysplastic syndrome in Pfizer BioNTech Covid Vaccine
- Myelodysplastic syndrome in Johnson and Johnson Covid Vaccine
Common drugs associated with Myelodysplastic syndrome:
All the drugs that are associated with Myelodysplastic syndrome:
- Myelodysplastic syndrome (1,283 drugs)
Common conditions associated with Myelodysplastic syndrome:
All the conditions that are associated with Myelodysplastic syndrome:
- Myelodysplastic syndrome (982 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on mercaptopurine (the active ingredients of Mercaptopurine) and Mercaptopurine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Peripheral Neuropathy and Drug Abuse And Dependence - 2 seconds ago
- Casodex and Aspartate Aminotransferase Increased - 11 seconds ago
- Simponi and Ruptured Eardrum - 26 seconds ago
- Sodium Bicarbonate and Renal Abscess - 30 seconds ago
- Thrombocytopenia in Advair Diskus 100/50, how severe and when it was recovered? - 46 seconds ago
- Adenocarcinoma and Neuropathy - Peripheral - 56 seconds ago
- Adenocarcinoma and Peripheral Neuropathy - 56 seconds ago
- Eliquis and Eupressyl drug interaction - 56 seconds ago
- Dicyclomine Hydrochloride and Febrile Neutropenia - 58 seconds ago
- Therapeutic Drug Levels in Lamotrigine, how severe and when it was recovered? - a minute ago